ClinicalTrials.govpublic full text
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab
renal cell carcinoma, melanoma, solid tumor, non-small cell lung cancer, head and neck squamous cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 369832
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.